Join John Bertrand, CEO of Digital Diagnostics as he joins DIA Personalized Medicine Conference December 8th. John will be joining the session titled Digital Health & Personalized Medicine where they will discuss the following:
Recent advances in mobile technologies and digital health have enabled sensor-based technologies for objective, quantitative, remote, and continuous monitoring of health and disease. These devices not only provide the ability to measure much more detailed disease phenotypes than traditional clinical examination, but also provide the ability to follow patients longitudinally with much higher frequency than is possible through other means.
Learning Objective : At the conclusion of this session, participants should be able to:
- Discuss current challenges around the pathways and level of evidence to enable qualification of a novel digital measure
- Identify flexibilities across industry on the technologies, study designs, and data analytic methodologies
- Discuss methods for advancing the development of these technologies and learn from recent successes